2014 Q2 Form 10-Q Financial Statement

#000123252414000080 Filed on August 05, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $291.2M $208.3M
YoY Change 39.84% 67.63%
Cost Of Revenue $30.70M $25.00M
YoY Change 22.8% 103.25%
Gross Profit $258.4M $181.5M
YoY Change 42.35% 63.97%
Gross Profit Margin 88.73% 87.17%
Selling, General & Admin $100.6M $77.51M
YoY Change 29.74% 35.44%
% of Gross Profit 38.91% 42.7%
Research & Development $20.09M $9.250M
YoY Change 117.19% 298.54%
% of Gross Profit 7.77% 5.1%
Depreciation & Amortization $34.70M $20.00M
YoY Change 73.5% 25.0%
% of Gross Profit 13.43% 11.02%
Operating Expenses $216.9M $131.2M
YoY Change 65.37% 54.69%
Operating Profit $74.29M $77.07M
YoY Change -3.6% 95.47%
Interest Expense -$11.43M -$7.142M
YoY Change 60.03% 382.24%
% of Operating Profit -15.38% -9.27%
Other Income/Expense, Net
YoY Change
Pretax Income $62.94M $65.79M
YoY Change -4.34% 74.48%
Income Tax $19.35M $23.61M
% Of Pretax Income 30.75% 35.88%
Net Earnings $43.66M $42.19M
YoY Change 3.49% 55.41%
Net Earnings / Revenue 14.99% 20.26%
Basic Earnings Per Share $0.73 $0.72
Diluted Earnings Per Share $0.70 $0.69
COMMON SHARES
Basic Shares Outstanding 59.52M shares 58.74M shares
Diluted Shares Outstanding 62.38M shares 61.57M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $268.3M $504.3M
YoY Change -46.8% 226.41%
Cash & Equivalents $268.3M $504.3M
Short-Term Investments $268.0M $504.0M
Other Short-Term Assets $18.47M $19.72M
YoY Change -6.33% 45.96%
Inventory $33.10M $28.13M
Prepaid Expenses $28.45M $21.41M
Receivables $160.8M $114.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $544.9M $734.2M
YoY Change -25.78% 144.37%
LONG-TERM ASSETS
Property, Plant & Equipment $38.46M $10.77M
YoY Change 257.19% 132.52%
Goodwill $760.3M $439.0M
YoY Change 73.19% -1.62%
Intangibles $1.680B $823.0M
YoY Change 104.14% -11.26%
Long-Term Investments
YoY Change
Other Assets $11.14M $5.502M
YoY Change 102.38% -71.38%
Total Long-Term Assets $2.611B $1.360B
YoY Change 92.02% -2.7%
TOTAL ASSETS
Total Short-Term Assets $544.9M $734.2M
Total Long-Term Assets $2.611B $1.360B
Total Assets $3.156B $2.094B
YoY Change 50.71% 23.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.56M $20.37M
YoY Change 59.84% -40.97%
Accrued Expenses $142.8M $96.77M
YoY Change 47.61% -22.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $9.473M $5.572M
YoY Change 70.01% -76.54%
Total Short-Term Liabilities $197.8M $184.3M
YoY Change 7.28% -4.15%
LONG-TERM LIABILITIES
Long-Term Debt $1.187B $546.7M
YoY Change 117.1% 23.08%
Other Long-Term Liabilities $29.18M $13.33M
YoY Change 118.87% 725.39%
Total Long-Term Liabilities $1.216B $560.1M
YoY Change 117.15% 25.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $197.8M $184.3M
Total Long-Term Liabilities $1.216B $560.1M
Total Liabilities $1.414B $744.4M
YoY Change 89.94% 16.65%
SHAREHOLDERS EQUITY
Retained Earnings -$53.95M -$29.26M
YoY Change 84.34% -90.08%
Common Stock $1.273B $1.185B
YoY Change 7.44% 5.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.280B $1.175B
YoY Change
Total Liabilities & Shareholders Equity $3.156B $2.094B
YoY Change 50.71% 23.32%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $43.66M $42.19M
YoY Change 3.49% 55.41%
Depreciation, Depletion And Amortization $34.70M $20.00M
YoY Change 73.5% 25.0%
Cash From Operating Activities $74.90M $8.700M
YoY Change 760.92% -88.7%
INVESTING ACTIVITIES
Capital Expenditures -$13.20M -$3.600M
YoY Change 266.67% -65.71%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$13.10M -$3.600M
YoY Change 263.89% -99.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -39.50M 47.50M
YoY Change -183.16% -89.86%
NET CHANGE
Cash From Operating Activities 74.90M 8.700M
Cash From Investing Activities -13.10M -3.600M
Cash From Financing Activities -39.50M 47.50M
Net Change In Cash 22.30M 52.60M
YoY Change -57.6% -437.18%
FREE CASH FLOW
Cash From Operating Activities $74.90M $8.700M
Capital Expenditures -$13.20M -$3.600M
Free Cash Flow $88.10M $12.30M
YoY Change 616.26% -85.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
32555000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21005000 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
160775000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
124805000 USD
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
31829000 USD
CY2014Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
39782000 USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
142843000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
119718000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5225000 USD
CY2014Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3209000 USD
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
6082000 USD
CY2014Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
7328000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10613000 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12818000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
56153000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
59946000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1220317000 USD
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1273159000 USD
us-gaap Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation
10551000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32476000 USD
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
792000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32367000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11506000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20263000 USD
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18552000 USD
CY2014Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
13136000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
7971000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
13915000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
22665000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38954000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
63977000 USD
CY2014Q2 us-gaap Assets
Assets
3155749000 USD
CY2013Q4 us-gaap Assets
Assets
2238221000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
864617000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
544912000 USD
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
636504000 USD
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
636504000 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-7900000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0 USD
CY2013Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
7960000 USD
CY2014Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
8476000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
636504000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
268255000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
387196000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
504307000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
117111000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-368249000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
6000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
73784000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
50799000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32713000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45198000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-347000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1059000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-46257000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
73784000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
32366000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
50799000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.39
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Risk</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents and marketable securities. Our investment policy permits investments in U.S. federal government and federal agency securities, corporate bonds or commercial paper issued by U.S. corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, and tax-exempt obligations of U.S. states, agencies and municipalities and places restrictions on credit ratings, maturities, and concentration by type and issuer. We are exposed to credit risk in the event of a default by the financial institutions holding our cash, cash equivalents and marketable securities and issuers of investments to the extent recorded on the balance sheet.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also subject to credit risk from our accounts receivable related to our product sales. We monitor our exposure within accounts receivable and record a reserve against uncollectible accounts receivable as necessary. We extend credit to pharmaceutical wholesale distributors and specialty pharmaceutical distribution companies, primarily in the United States, and to other international distributors and hospitals. Customer creditworthiness is monitored and collateral is not required. We monitor deteriorating economic conditions in certain European countries which may result in variability of the timing of cash receipts and an increase in the average length of time that it takes to collect accounts receivable outstanding. Historically, we have not experienced significant credit losses on our accounts receivable and we do not expect to have write-offs or adjustments to accounts receivable which would have a material adverse effect on our financial position, liquidity or results of operations. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2014</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> customers accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">81%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, including Express Scripts Specialty Distribution Services, Inc. and its affiliate CuraScript, Inc., or Express Scripts, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">65%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, Idis Limited, which accounted for </font><font style="font-family:inherit;font-size:10pt;">8%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, and Accredo Health Group, Inc., or Accredo, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">5%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable.&#160; As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> customers accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">85%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, including Express Scripts, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">69%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, and Accredo, which accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">9%</font><font style="font-family:inherit;font-size:10pt;"> of gross accounts receivable.&#160;</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We depend on single source suppliers and manufacturers for each of our products, product candidates and their active pharmaceutical ingredients.</font></div></div>
CY2013Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
4388000 USD
CY2014Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
18041000 USD
CY2013Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
14605000 USD
CY2014Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
24427000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9064000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-18598000 USD
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1138000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1138000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5718000 USD
CY2014Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5148000 USD
CY2014Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
35869000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
33613000 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
74597000 USD
CY2014Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
96495000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
6259000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
6259000 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
168497000 USD
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
456611000 USD
us-gaap Depreciation
Depreciation
3169000 USD
us-gaap Depreciation
Depreciation
1170000 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-2077000 USD
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
233000 USD
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.359
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.321
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2014Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.307
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.325
CY2013Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3535000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
6348000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
9702000 USD
CY2014Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
5416000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
792000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
792000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
181552000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
231609000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
894744000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
62124000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
111525000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
115030000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
115121000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
119472000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1649625000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
959689000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1418016000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
778137000 USD
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1897000 USD
CY2014Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2279000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-40000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3749000 USD
CY2014Q2 us-gaap Goodwill
Goodwill
760314000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
450456000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
308642000 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
1216000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2014Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
32806000 USD
CY2013Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
32806000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
126849000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65790000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13676000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
62936000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23605000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19350000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36377000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41239000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4707000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-31555000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
39015000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21889000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5454000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-21898000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7749000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-821000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-557000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-492000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6104000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3302000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
3365000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2617000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
6709000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
8461000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-936000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14672000 USD
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1537000 shares
CY2014Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
566000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1417000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1456000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1414000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2293000 shares
CY2014Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1911613000 USD
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
993948000 USD
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1680004000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
812396000 USD
CY2014Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-11429000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-14541000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-21505000 USD
CY2013Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7142000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14862000 USD
CY2014Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
17697000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
33098000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
28669000 USD
CY2014Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3155000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3506000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10301000 USD
CY2014Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12246000 USD
CY2014Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
6753000 USD
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
4587000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2238221000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3155749000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
204028000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
197768000 USD
CY2014Q2 us-gaap Long Term Debt
LongTermDebt
1196433000 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
549976000 USD
CY2014Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
9473000 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5572000 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
544404000 USD
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1186960000 USD
CY2014Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
7495000 USD
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
417000 USD
CY2014Q2 us-gaap Minority Interest
MinorityInterest
396000 USD
CY2013Q4 us-gaap Minority Interest
MinorityInterest
0 USD
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
136640000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
458207000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50589000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10010000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-970336000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
78609000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
143647000 USD
us-gaap Net Income Loss
NetIncomeLoss
85610000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
42185000 USD
us-gaap Net Income Loss
NetIncomeLoss
-48991000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
43659000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1062000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2014Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-73000 USD
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
136578000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Operating Expenses
OperatingExpenses
259236000 USD
us-gaap Operating Expenses
OperatingExpenses
530517000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
216939000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
131186000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
77066000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
7632000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
145253000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
74291000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
27767000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
910000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3956000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
7292000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
10021000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
174000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
5414000 USD
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19967000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12100000 USD
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
18468000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
33843000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7304000 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11135000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3796000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11220000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8614000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3796000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11826000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3796000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11826000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11220000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8614000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20040000 USD
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29175000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3251000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2907000 USD
CY2014Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
74000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
-114000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
197000 USD
CY2013Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
-385000 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
0 USD
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
35100000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
23487000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
53578000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1597000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10551000 USD
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
136640000 USD
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
828676000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1300000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
14660000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4710000 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7183000 USD
CY2014Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
28447000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
553425000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
636355000 USD
CY2014Q2 us-gaap Profit Loss
ProfitLoss
43586000 USD
us-gaap Profit Loss
ProfitLoss
-50053000 USD
us-gaap Profit Loss
ProfitLoss
85610000 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
42185000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24859000 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
51280000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14246000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38462000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
4804000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
463124000 USD
CY2013Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
4000000 USD
CY2014Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
127000000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38199000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20090000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15997000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9250000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53946000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18532000 USD
us-gaap Revenues
Revenues
404489000 USD
us-gaap Revenues
Revenues
538149000 USD
CY2014Q2 us-gaap Revenues
Revenues
291230000 USD
CY2013Q2 us-gaap Revenues
Revenues
208252000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
401216000 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
289100000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
206564000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
534086000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
206919000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
148034000 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
100556000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77506000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
20263000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
32367000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
23487000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
1279691000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1295534000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1295534000 USD
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1280087000 USD
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
336000 USD
CY2014Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
5500000 USD
CY2014Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance On First Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
37400000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</font></div></div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59025000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61541000 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62378000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61568000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58737000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59519000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58548000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59025000 shares
CY2014Q2 jazz Accrued Construction In Progress
AccruedConstructionInProgress
3298000 USD
CY2013Q4 jazz Accrued Construction In Progress
AccruedConstructionInProgress
450000 USD
CY2013Q4 jazz Accrued Interest
AccruedInterest
4150000 USD
CY2014Q2 jazz Accrued Interest
AccruedInterest
6174000 USD
CY2013Q4 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
38772000 USD
CY2014Q2 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
45871000 USD
CY2014Q2 jazz Capital Redemption Reserve
CapitalRedemptionReserve
471000 USD
CY2013Q4 jazz Capital Redemption Reserve
CapitalRedemptionReserve
471000 USD
CY2014Q2 jazz Computer Equipment Gross
ComputerEquipmentGross
6550000 USD
jazz Increase Decreasein Contingent Consideration
IncreaseDecreaseinContingentConsideration
-14900000 USD
CY2013Q4 jazz Computer Equipment Gross
ComputerEquipmentGross
5610000 USD
CY2013Q4 jazz Contingent Consideration Current
ContingentConsiderationCurrent
50000000 USD
CY2014Q2 jazz Contingent Consideration Current
ContingentConsiderationCurrent
0 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
52251000 USD
CY2014Q2 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
30692000 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
61616000 USD
CY2013Q2 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
25031000 USD
CY2014Q2 jazz Entity Wide Accounts Receivable Major Customer Percentage
EntityWideAccountsReceivableMajorCustomerPercentage
0.81
CY2013Q4 jazz Entity Wide Accounts Receivable Major Customer Percentage
EntityWideAccountsReceivableMajorCustomerPercentage
0.85
jazz Fair Value Inventory Step Up Adjustment
FairValueInventoryStepUpAdjustment
2631000 USD
jazz Fair Value Inventory Step Up Adjustment
FairValueInventoryStepUpAdjustment
10477000 USD
CY2013Q2 jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
-3749000 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
-3749000 USD
CY2014Q2 jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
jazz Increase Decreasein Contingent Consideration
IncreaseDecreaseinContingentConsideration
0 USD
CY2014Q2 jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
32795000 USD
CY2013Q2 jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
19399000 USD
jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
38954000 USD
jazz Intangible Asset Amortization From Continuing Operations
IntangibleAssetAmortizationFromContinuingOperations
63977000 USD
CY2013Q4 jazz Inventory Step Up Value
InventoryStepUpValue
200000 USD
CY2013Q4 jazz Landand Buildings Gross
LandandBuildingsGross
0 USD
CY2014Q2 jazz Landand Buildings Gross
LandandBuildingsGross
1686000 USD
CY2013Q4 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2014Q2 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2013Q4 jazz Number Of Customers With Significant Accounts Receivable Balance
NumberOfCustomersWithSignificantAccountsReceivableBalance
5 Customer
CY2014Q2 jazz Number Of Customers With Significant Accounts Receivable Balance
NumberOfCustomersWithSignificantAccountsReceivableBalance
5 Customer
jazz Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination
PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination
127000000 USD
jazz Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination
PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination
4000000 USD
jazz Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants
ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptionsAndWarrants
15463000 USD
jazz Proceeds From Employee Stock Purchases And Exercise Of Stock Options And Warrants
ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptionsAndWarrants
31642000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
1925000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
1236000 USD
CY2014Q2 jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
2130000 USD
CY2013Q2 jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
1688000 USD
jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
3273000 USD
jazz Royalties And Contract Revenues
RoyaltiesAndContractRevenues
4063000 USD
CY2013Q4 jazz Sales Return Reserve
SalesReturnReserve
21110000 USD
CY2014Q2 jazz Sales Return Reserve
SalesReturnReserve
17214000 USD
jazz Stock Issued During Period Employee Plansand Warrants Amount
StockIssuedDuringPeriodEmployeePlansandWarrantsAmount
31642000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001232524
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
60221128 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Jazz Pharmaceuticals plc
dei Trading Symbol
TradingSymbol
JAZZ

Files In Submission

Name View Source Status
0001232524-14-000080-index-headers.html Edgar Link pending
0001232524-14-000080-index.html Edgar Link pending
0001232524-14-000080.txt Edgar Link pending
0001232524-14-000080-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jazz-20140630.xml Edgar Link completed
jazz-20140630.xsd Edgar Link pending
jazz-20140630_cal.xml Edgar Link unprocessable
jazz-20140630_def.xml Edgar Link unprocessable
jazz-20140630_lab.xml Edgar Link unprocessable
jazz-20140630_pre.xml Edgar Link unprocessable
jazz2014q2doc.htm Edgar Link pending
jazzq22014ex311.htm Edgar Link pending
jazzq22014ex312.htm Edgar Link pending
jazzq22014ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending